CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 2 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$558,240
-25.4%
160,8760.0%0.00%
Q2 2023$748,073
+11.0%
160,876
+10.2%
0.00%
Q1 2023$674,243
-42.1%
145,940
+1.2%
0.00%
Q4 2022$1,164,708
+59.8%
144,147
+9.9%
0.00%
Q3 2022$729,000
+16.6%
131,205
+9.5%
0.00%
Q2 2022$625,000
-36.5%
119,783
+0.1%
0.00%
Q1 2022$984,000
-39.7%
119,667
+9.2%
0.00%
Q4 2021$1,631,000
-20.0%
109,549
+1.6%
0.00%
-100.0%
Q3 2021$2,038,000
+5.4%
107,873
+3.7%
0.00%0.0%
Q2 2021$1,934,000
+4.4%
103,998
+27.8%
0.00%0.0%
Q1 2021$1,853,000
+21.5%
81,398
+15.9%
0.00%0.0%
Q4 2020$1,525,000
+130.4%
70,225
+6.6%
0.00%
Q3 2020$662,000
+76.5%
65,859
+36.5%
0.00%
Q2 2020$375,000
+62.3%
48,231
+113.5%
0.00%
Q1 2020$231,000
-7.2%
22,5920.0%0.00%
Q4 2019$249,000
+20.9%
22,5920.0%0.00%
Q3 2019$206,000
-20.2%
22,5920.0%0.00%
Q2 2019$258,000
+72.0%
22,592
+72.3%
0.00%
Q1 2019$150,000
+26.1%
13,1100.0%0.00%
Q4 2018$119,00013,1100.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$33,918,00014.78%
Samsara BioCapital, LLC 1,675,579$31,149,0003.84%
First Light Asset Management, LLC 2,072,875$38,535,0002.31%
AJU IB Investment Co., Ltd. 175,000$3,253,0001.88%
FRAZIER MANAGEMENT LLC 1,001,421$18,616,0001.72%
Opaleye Management Inc. 496,900$9,237,0001.53%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$2,590,0000.68%
Parkman Healthcare Partners LLC 163,389$3,037,0000.66%
Eventide Asset Management 2,370,975$44,076,0000.59%
BVF INC/IL 826,825$15,371,0000.58%
View complete list of SUTRO BIOPHARMA INC shareholders